GeneThera Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
2016
2017
Cost of Goods Sold (COGS) incl. D&A
283.40
36.30
15.50
12.80
-
-
-
Gross Income
283.40
36.30
15.50
12.80
-
-
-
SG&A Expense
831.00
1,415.30
1,084.40
595.80
900.90
707.20
645
EBIT
1,114.40
1,451.60
1,100.00
608.60
900.90
-
645
Unusual Expense
-
355.80
-
66.90
-
78.90
33.90
Non Operating Income/Expense
0.90
3.30
40.10
-
-
13
-
Interest Expense
6.60
1.10
-
4.30
184.60
137.70
146.60
Pretax Income
1,121.90
1,811.80
1,059.80
546.10
1,085.50
778.90
757.70
Consolidated Net Income
1,121.90
1,811.80
1,059.80
546.10
1,085.50
778.90
757.70
Net Income
1,100.80
1,791.40
1,056.90
546.10
1,085.50
778.90
757.70
Net Income After Extraordinaries
1,100.80
1,791.40
1,056.90
546.10
1,085.50
778.90
757.70
Net Income Available to Common
1,100.80
1,791.40
1,056.90
546.10
1,085.50
778.90
757.70
EPS (Basic)
0.05
0.07
0.04
0.02
0.03
0.02
0.02
Basic Shares Outstanding
24,411.90
25,041.90
28,825.50
32,802.20
36,558.30
38,688.60
40,065
EPS (Diluted)
0.05
0.07
0.04
0.02
0.03
0.02
0.02
Diluted Shares Outstanding
24,411.90
25,041.90
28,825.50
32,802.20
36,558.30
38,688.60
40,065
EBITDA
1,110.00
1,415.30
1,084.40
595.90
900.90
707.20
-
Minority Interest Expense
21.10
20.40
3.00
-
-
-
-
About GeneThera
View Profile
